-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on NeuroPace, Lowers Price Target to $12

Benzinga·11/16/2026 17:42:03
Mizuho analyst Anthony Petrone maintains NeuroPace (NASDAQ:NPCE) with a Outperform and lowers the price target from $22 to $12.